U.S. Stem Cell, Inc. USRM
Last Post: 07/31/2023 7:35:39 PM
Board Marks: 49
Posts Today: 0
Board Views Today: 24
$USRM Very bad news - over a year in coming.
Down 58% today $0.0077
Down over 92% in 10 months. 5/9/18
iHang board
FDA Notches Court Win in Case Over Stem-Cell Clinic
Another shoe to drop. A possible cease & desist order.
.....................................................
U.S. Department of Justice Files Lawsuit
at Request of FDA to Stop U.S. Stem Cell Clinic
from Performing Autologous Stem Cell Procedure
USRM Will Vigorously Defend Medical Freedom of Americans
May 9, 2018 < >
Dr. Kristin Comella, USRM’s Chief Science Officer
OTC
Website float 327M
100% sell
Filings and news
Developing the Future of Medicine.
There are 500 times more stem cells from fat (adipose tissue)
as compared to bone marrow - and much less invasive to retrieve.
We have treated over 4000 patients
We have trained over 600 practitioners
We have spent more than $125 million in research and development
We do not utilize harmful drugs to isolate cells from peripheral blood.
We have worked with several countries to help develop and write the regulations for stem cell therapy
Our protocols are being utilized in 6 continents
We are the inventors and developers of our own therapies
Treatment for Patients
Solutions for Veterinarians
Training for Physicians
Myocell
a muscle stem cell therapy
MyoCell SDF-1
Autologous cell therapy treatment for
severe chronic damage in the heart;
AdipoCell
The fat cells we use.
Clinical Trials and Recent Publications
US Stem Cell training courses
[/b]
Down 58% today $0.0077
Down over 92% in 10 months. 5/9/18
iHang board
FDA Notches Court Win in Case Over Stem-Cell Clinic
Another shoe to drop. A possible cease & desist order.
.....................................................
U.S. Department of Justice Files Lawsuit
at Request of FDA to Stop U.S. Stem Cell Clinic
from Performing Autologous Stem Cell Procedure
USRM Will Vigorously Defend Medical Freedom of Americans
May 9, 2018 < >
Dr. Kristin Comella, USRM’s Chief Science Officer
OTC
Website float 327M
100% sell
Filings and news
Developing the Future of Medicine.
There are 500 times more stem cells from fat (adipose tissue)
as compared to bone marrow - and much less invasive to retrieve.
We have treated over 4000 patients
We have trained over 600 practitioners
We have spent more than $125 million in research and development
We do not utilize harmful drugs to isolate cells from peripheral blood.
We have worked with several countries to help develop and write the regulations for stem cell therapy
Our protocols are being utilized in 6 continents
We are the inventors and developers of our own therapies
Treatment for Patients
Solutions for Veterinarians
Training for Physicians
Myocell
a muscle stem cell therapy
MyoCell SDF-1
Autologous cell therapy treatment for
severe chronic damage in the heart;
AdipoCell
The fat cells we use.
Clinical Trials and Recent Publications
US Stem Cell training courses
[/b]
U.S. Stem Cell, Inc. (OTCMRKTS: USRM) Stock Message Board
Post
Subject
Author
Posted On
